🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Poly Medicure Limited POLYMED NIFTY_SMALLNSEPHARMA

Healthcare · Medical Instruments & Supplies · India
https://www.polymedicure.com

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

READ MORE ›
₹1,349.70
-40.82% 1Y

Market & Price

Market Cap
₹13,696.69 Cr
Current Price
₹1,349.70
High / Low (52W)
₹2,280.79 / ₹1,191.10
Beta
0.12

Valuation

Stock P/E
42.55
Industry PE
37.60
Forward P/E
28.80
PEG Ratio
-
Book Value
₹287.91
Price to Book
4.69
P/S
7.30
EV/EBITDA
29.96
Dividend Yield
0.26%

Profitability & Returns

ROCE
13.33%
ROE
10.85%
ROA
5.75%
Profit Margin
17.18%
Op Margin
13.50%
EPS (Latest Qtr)
₹6.53
EPS (TTM)
₹31.72

Balance Sheet & Liquidity

Debt/Equity
0.11
Quick Ratio
2.36
Current Ratio
3.37
Debt
₹353.58 Cr
Total Assets
₹3,918.57 Cr
Current Assets
₹1,941.73 Cr
Working Capital
₹1,366.21 Cr

Ownership

Promoter Holding
67.91%
Chg in Prom Hold
-
FII / Inst Holding
21.80%
Chg in FII Hold
-0.13%

Financial Snapshot

Enterprise Value
₹13,250.69 Cr
Total Revenue (TTM)
₹1,875.26 Cr
EBITDA
₹442.32 Cr
Free Cash Flow
₹-309.36 Cr
Operating Cash Flow
₹246.37 Cr
Shares Outstanding
₹10.14 Cr
Gross Margin
68.17%
Payout Ratio
11.02%

Growth (CAGR)

Revenue 5Y
19.15%
Profit 5Y
22.71%
Revenue (YoY)
21.30%
Earnings (YoY)
-26.80%

PROS

  • Compounding revenue at 19.1% over 5 years.
  • Profit CAGR of 22.7% over 5 years.

CONS

  • Trading 40.8% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 POLYMED Poly Medicure Limited NIFTY_SMALLNSEPHARMA 1,349.70 42.55 ₹13,696.69 Cr 0.26% 13.33% 10.85% 19.15% 22.71%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
Ad space

Quarterly Results

Figures in INR.

Metric Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --440.83 Cr403.21 Cr443.88 Cr493.66 Cr534.51 Cr
Cost of Revenue --148.15 Cr127.23 Cr135.66 Cr312.54 Cr178.16 Cr
Gross Profit --292.68 Cr275.98 Cr308.22 Cr181.12 Cr356.35 Cr
Operating Expenses --194.25 Cr193.10 Cr218.47 Cr255.47 Cr284.18 Cr
Operating Income --98.43 Cr82.88 Cr89.75 Cr-74.35 Cr72.17 Cr
EBITDA --146.18 Cr149.15 Cr149.59 Cr132.33 Cr129.86 Cr
Interest Expense --2.17 Cr2.95 Cr2.97 Cr5.96 Cr6.41 Cr
Pretax Income --122.85 Cr122.95 Cr121.69 Cr97.61 Cr85.22 Cr
Tax Provision --31.02 Cr29.86 Cr29.89 Cr26.80 Cr20.18 Cr
Net Income --91.83 Cr93.08 Cr91.83 Cr70.93 Cr65.04 Cr
Diluted EPS --8.929.179.066.996.53

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -1,108.66 Cr1,365.69 Cr1,669.83 Cr1,875.26 Cr
Cost of Revenue -509.32 Cr604.32 Cr555.44 Cr596.81 Cr
Gross Profit -599.34 Cr761.38 Cr1,114.39 Cr1,278.45 Cr
Operating Expenses -381.49 Cr458.72 Cr744.18 Cr951.65 Cr
Operating Income -217.85 Cr302.65 Cr370.20 Cr326.80 Cr
EBITDA -303.20 Cr418.89 Cr547.69 Cr561.28 Cr
Interest Expense -8.54 Cr10.70 Cr12.00 Cr18.29 Cr
Pretax Income -237.49 Cr344.27 Cr452.52 Cr427.47 Cr
Tax Provision -58.21 Cr86.01 Cr113.96 Cr96.18 Cr
Net Income -179.28 Cr258.26 Cr338.56 Cr331.29 Cr
Diluted EPS 15.2718.6726.9034.11-

Compounded Sales Growth

5 Years:19.15%
1 Year:21.30%

Compounded Profit Growth

5 Years:22.71%
1 Year:-26.80%

Stock Price Performance

1 Year:-40.82%
6 Months:-29.29%
3 Months:+4.86%
1 Month:-10.74%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -1,577.21 Cr1,858.67 Cr3,192.45 Cr3,918.57 Cr
Current Assets -806.69 Cr841.60 Cr1,917.00 Cr1,941.73 Cr
Cash & Equivalents -7.06 Cr12.05 Cr8.70 Cr51.23 Cr
Inventory -208.65 Cr221.03 Cr285.57 Cr433.84 Cr
Receivables -235.43 Cr269.94 Cr349.73 Cr531.17 Cr
Total Liabilities -335.58 Cr388.62 Cr426.79 Cr769.32 Cr
Current Liabilities -293.30 Cr351.21 Cr370.17 Cr575.52 Cr
Long Term Debt -17.50 Cr84.05 L052.09 Cr
Total Debt -149.02 Cr173.90 Cr180.25 Cr353.58 Cr
Total Equity -1,241.63 Cr1,470.05 Cr2,765.66 Cr3,106.17 Cr
Shares Outstanding -9.59 Cr9.60 Cr10.13 Cr10.14 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -191.05 Cr266.08 Cr233.05 Cr246.37 Cr
Investing Cash Flow --179.24 Cr-240.94 Cr-1,187.18 Cr-225.38 Cr
Financing Cash Flow --12.51 Cr-20.15 Cr950.51 Cr20.15 Cr
Capital Expenditure --239.27 Cr-277.02 Cr-331.03 Cr-308.39 Cr
Free Cash Flow --48.22 Cr-10.93 Cr-97.98 Cr-62.02 Cr
Net Change in Cash --69.49 L4.99 Cr-3.63 Cr41.14 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -54.1%55.8%66.7%68.2%
Operating Margin % -19.6%22.2%22.2%17.4%
Net Margin % -16.2%18.9%20.3%17.7%
ROE % -14.4%17.6%12.2%10.7%
ROCE % -17.0%20.1%13.1%9.8%

Shareholding Pattern

Insiders
67.91%
Institutions
21.80%
Public Float
67.93%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for POLYMED

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks